HK1205788A1 - 增加辨認出致命前列腺癌 - Google Patents

增加辨認出致命前列腺癌

Info

Publication number
HK1205788A1
HK1205788A1 HK15106199.9A HK15106199A HK1205788A1 HK 1205788 A1 HK1205788 A1 HK 1205788A1 HK 15106199 A HK15106199 A HK 15106199A HK 1205788 A1 HK1205788 A1 HK 1205788A1
Authority
HK
Hong Kong
Prior art keywords
psma
identifies
elevated
prostate cancers
lethal prostate
Prior art date
Application number
HK15106199.9A
Other languages
English (en)
Inventor
Neil H Bander
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of HK1205788A1 publication Critical patent/HK1205788A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15106199.9A 2012-02-24 2015-06-30 增加辨認出致命前列腺癌 HK1205788A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261602900P 2012-02-24 2012-02-24
PCT/US2013/000045 WO2013126147A2 (en) 2012-02-24 2013-02-22 Elevated psma identifies lethal prostate cancers

Publications (1)

Publication Number Publication Date
HK1205788A1 true HK1205788A1 (zh) 2015-12-24

Family

ID=49003541

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106199.9A HK1205788A1 (zh) 2012-02-24 2015-06-30 增加辨認出致命前列腺癌

Country Status (6)

Country Link
US (2) US20130225541A1 (zh)
EP (2) EP3064945A1 (zh)
JP (2) JP6501524B2 (zh)
CA (1) CA2865282A1 (zh)
HK (1) HK1205788A1 (zh)
WO (1) WO2013126147A2 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2865774A1 (en) * 2012-02-28 2013-09-06 Cornell University Psma as a biomarker for androgen activity in prostate cancer
CA3036754A1 (en) 2016-10-27 2018-05-03 Progenics Pharmaceuticals, Inc. Network for medical image analysis, decision support system, and related graphical user interface (gui) applications
MA47325A (fr) 2017-01-20 2019-11-27 Juno Therapeutics Gmbh Conjugués de surface cellulaire et compositions cellulaires et méthodes associées
EP3607319A1 (en) 2017-04-07 2020-02-12 Juno Therapeutics, Inc. Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods
JP7568628B2 (ja) 2019-01-07 2024-10-16 エクシーニ ディアグノスティクス アーべー プラットホーム非依存の全身画像セグメント化のためのシステムおよび方法
AU2020261370A1 (en) 2019-04-24 2021-10-14 Exini Diagnostics Ab Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
US11900597B2 (en) 2019-09-27 2024-02-13 Progenics Pharmaceuticals, Inc. Systems and methods for artificial intelligence-based image analysis for cancer assessment
EP4126209A4 (en) * 2020-03-26 2024-06-19 Ramirez-Fort, Marigdalia, Kaleth TREATMENTS WITH ULTRAVIOLET RADIATION

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE337011T1 (de) * 2001-02-07 2006-09-15 Beth Israel Hospital Modifizierte psma-liganden und deren verwendung
AU2002318169B2 (en) * 2001-06-01 2007-10-18 Cornell Research Foundation, Inc. Modified antibodies to prostate-specific membrane antigen and uses thereof
ATE408712T1 (de) * 2003-01-10 2008-10-15 Millennium Pharm Inc Verfahren zur bestimmung des wiederauftretens von prostata krebs
US7560531B2 (en) * 2003-05-29 2009-07-14 Diadexus, Inc. Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
JP2010507645A (ja) * 2006-10-25 2010-03-11 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 前立腺癌を検出するための造影剤
EP2209498A2 (en) * 2007-10-03 2010-07-28 Cornell University Treatment of proliferative disorders using antibodies to psma
WO2009127046A1 (en) * 2008-04-14 2009-10-22 Proscan Rx Pharma Inc. Prostate specific membrane antigen antibodies and antigen binding fragments
CN102308212A (zh) * 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
ES2712732T3 (es) * 2009-02-17 2019-05-14 Cornell Res Foundation Inc Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico
EP2408465A4 (en) * 2009-03-17 2012-11-28 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR DETECTING CANCER

Also Published As

Publication number Publication date
EP2817629A4 (en) 2016-01-13
WO2013126147A3 (en) 2014-12-24
EP2817629A2 (en) 2014-12-31
JP2019144254A (ja) 2019-08-29
US20180088120A1 (en) 2018-03-29
JP2015513083A (ja) 2015-04-30
CA2865282A1 (en) 2013-08-29
JP6501524B2 (ja) 2019-04-17
EP3064945A1 (en) 2016-09-07
US20130225541A1 (en) 2013-08-29
WO2013126147A2 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
IL246067A0 (en) Classification of prostate cancer
GB2515970B (en) Cable holder
HK1205788A1 (zh) 增加辨認出致命前列腺癌
EP2828756A4 (en) STORING MEMORY INDEPENDENT MEMORY CONTROLLER
EP2837006A4 (en) WIRES WITH CNS SHIELDING
HK1207375A1 (zh) 呱啶基吡唑並吡啶衍生物
EP2874517A4 (en) SEAT LIFTING ARRANGEMENT
IL236295A (en) The history of indanesulfamide
GB201222308D0 (en) Support assembly
PL2815136T3 (pl) Układ montażowy
EP2905847A4 (en) ARRANGEMENT
EP2914323A4 (en) INTUMASK ARRANGEMENT
HK1211025A1 (zh) 吲哚啉類
GB2498536B (en) Electrical assembly
EP2924696A4 (en) INSULATED WIRE
EP2881600A4 (en) TOGETHER
EP2873660A4 (en) INDOLCARBOXAMIDDERIVAT
GB201201828D0 (en) Luminaire
GB2507515B (en) An assembly
EP2842958A4 (en) NAPHTHOBISTHIADIAZOLDERIVAT
IL222989A (en) Combat head
PL2660403T3 (pl) Uchwyt do materiału izolacyjnego
HK1204621A1 (zh) -烷酰基氨基- -吡唑啉酮衍生物
GB2507377B (en) Support assembly
EP2833057A4 (en) LIGHTING ARRANGEMENT